We are live on ! Find out more
GALT icon

Galectin Therapeutics
GALT

65 hedge funds and large institutions have $58.6M invested in Galectin Therapeutics in 2014 Q2 according to their latest regulatory filings, with 23 funds opening new positions, 22 increasing their positions, 12 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

83% more repeat investments, than reductions

Existing positions increased: 22 | Existing positions reduced: 12

77% more first-time investments, than exits

New positions opened: 23 | Existing positions closed: 13

18% more funds holding

Funds holding: 55 → 65 (+10)

9% more capital invested

Capital invested by funds: $53.9M → $58.6M (+$4.73M)

45% less call options, than puts

Call options by funds: $1.92M | Put options by funds: $3.46M

Holders
65
Holders Change
+10
Holders Change %
+18.18%
% of All Funds
1.87%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
23
Increased
22
Reduced
12
Closed
13
Calls
$1.92M
Puts
$3.46M
Net Calls
-$1.54M
Net Calls Change
+$3.75M

Top Buyers

Rank Fund Capital Flow
1
CAM
Cormorant Asset Management
Massachusetts
+$5.63M
2
BFA
BlackRock Fund Advisors
California
+$4.88M
3
BIT
BlackRock Institutional Trust
California
+$2.43M
4
State Street
State Street
Massachusetts
+$2.12M
5
TCIM
TIAA CREF Investment Management
New York
+$824K

Top Sellers

Rank Fund Capital Flow
1
MP
Mangrove Partners
Connecticut
-$3.06M
2
BBA
Baker Bros. Advisors
New York
-$2.49M
3
EI
EAM Investors
California
-$2.48M
4
DCM
Driehaus Capital Management
Illinois
-$2.04M
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$1.78M
Name Holding Trade Value Shares
Change 		Change in
Stake
TA
26
Teachers Advisors
New York
$352K +$317K +25,461 New
SG Americas Securities
27
SG Americas Securities
New York
$342K +$308K +24,744 New
California Public Employees Retirement System
28
California Public Employees Retirement System
California
$324K – – –
Jane Street
29
Jane Street
New York
$264K +$71.5K +5,745 +43%
State Board of Administration of Florida Retirement System
30
State Board of Administration of Florida Retirement System
Florida
$253K +$228K +18,318 New
Commonwealth Equity Services
31
Commonwealth Equity Services
Massachusetts
$236K +$19.5K +1,565 +10%
FIM
32
Freedom Investment Management
Connecticut
$215K +$5.22K +419 +3%
MLICM
33
Metropolitan Life Insurance Company (MetLife)
New York
$204K +$184K +14,775 New
TRCT
34
Tower Research Capital (TRC)
New York
$201K +$181K +14,506 +14,506%
RhumbLine Advisers
35
RhumbLine Advisers
Massachusetts
$192K +$173K +13,930 New
NFA
36
Nationwide Fund Advisors
Ohio
$190K +$171K +13,766 New
VOYA Investment Management
37
VOYA Investment Management
Georgia
$188K +$170K +13,649 New
SCM
38
Stevens Capital Management
Pennsylvania
$184K +$165K +13,288 New
SWP
39
Stratos Wealth Partners
Ohio
$180K +$161K +12,900 New
Manulife (Manufacturers Life Insurance)
40
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$164K +$146K +11,739 +7,477%
AIG
41
American International Group
New York
$163K +$147K +11,784 New
GC
42
Guggenheim Capital
Illinois
$157K +$11K +883 +8%
PAM
43
Panagora Asset Management
Massachusetts
$131K -$278K -22,347 -70%
Creative Planning
44
Creative Planning
Kansas
$106K – – –
BA
45
BlackRock Advisors
Delaware
$104K +$93.9K +7,543 New
SO
46
STRS Ohio
Ohio
$84K +$75.9K +6,100 New
Wells Fargo
47
Wells Fargo
California
$81K -$34.3K -2,755 -32%
Bank of America
48
Bank of America
North Carolina
$75K -$21.2K -1,700 -24%
AllianceBernstein
49
AllianceBernstein
Tennessee
$55K +$44.7K +3,587 +869%
U
50
UBS
Switzerland
$40K -$684K -54,983 -95%
1
2
3 4

GALT Hedge Fund Activity: Q2 2014 in Review

65 of the 3,479 institutional investors tracked by Wall St. Rank reported a position in Galectin Therapeutics (GALT) for Q2 2014, worth a combined $58.6M — up 8.8% from $53.9M a quarter earlier.

Buyers outnumbered sellers: 23 funds opened new GALT positions and 13 closed out — a net gain of 10 holders — while 22 added to existing stakes and 12 trimmed.

The largest buyer was Cormorant Asset Management, adding an estimated $5.63M. The largest seller was Mangrove Partners, exiting entirely with an estimated $3.06M sold.

  • 65 institutional investors held Galectin Therapeutics (GALT) as of Q2 2014, up from 55 in Q1 2014.
  • Funds reported $58.6M of Galectin Therapeutics stock for Q2 2014, up 8.8% quarter-over-quarter.
  • 23 funds opened new Galectin Therapeutics positions in Q2 2014 and 13 closed out, a net change of +10 holders.
  • The largest Galectin Therapeutics buyer in Q2 2014 was Cormorant Asset Management, an estimated $5.63M added.
  • The largest Galectin Therapeutics seller in Q2 2014 was Mangrove Partners, an estimated $3.06M sold.

Based on aggregated 13F filings for Q2 2014.